Clinical Trial Update: Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Phase II trial evaluating everolimus as first-line therapy for metastatic kidney cancer has been terminated. The update notes the study status as TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Kidney Cancer | Phase 2 | Status: TERMINATED